Zehra Dhanani, MBBS, lung transplant fellow at Temple University Hospital, presented research at the International Society for Heart and Lung Transplantation annual meeting in Boston that found patients taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation. MedPageToday and Healio Pulmonology covered the abstract’s findings.